Evaluation finds high treatment compliance and satisfaction with a single-pill regimen in postmenopausal women, suggesting favorable outcomes.
The monthly single-pill treatment regimen of ibandronic acid 150 mg and cholecalciferol 22,400 IU demonstrated high treatment compliance, persistence and patient satisfaction with a favorable safety profile and was well tolerated after six months of treatment.
No takes yet. Share an insight, caveat, or question.
Neves et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: